News

The tool has the potential to assist with preterm birth, labor management and clinical decisionmaking.

NIH-funded technique enables automatic detection of placental compartments, oxygen status and structural abnormalities.

Computational analysis of the word usage in personal stories of recent birthing experiences can identify women likely to develop PTSD related to childbirth, suggests an NIH-funded study. The findings may aid development of a low-cost screening tool to help diagnose and treat childbirth-related PTSD.

Read about NICHD’s research findings and activities from 2022.

The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.

The Pfizer-BioNTech and Moderna COVID-19 vaccines may offer slightly more protection during pregnancy against SARS-CoV-2, compared to the Jansen/Johnson & Johnson vaccine, suggests a study funded by the National Institutes of Health. Vaccination during the first and third trimesters appears to result in higher antibody-stimulated immune responses than vaccination in the second trimester. It also may lead to greater transfer of antibodies from maternal blood to the placenta.

Giving the hormone adiponectin to pregnant mice with obesity prevented later life obesity and related health conditions in their offspring, according to a study funded by the National Institutes of Health. The findings suggest that adiponectin, a hormone produced by fat cells, could play a role in reducing the lifelong obesity risk of children born to mothers with obesity during pregnancy.

Clinical research networks bring together scientists, clinicians, and community stakeholders to identify important clinical questions and design and conduct high-quality studies to answer them. Scientific evidence generated by such studies can impact clinical care, as several recent findings from NICHD’s networks demonstrate.

Vaccinating women against SARS-CoV-2 in mid to late pregnancy could provide their infants at least some protection against COVID-19 through six months of age, suggests a small study funded by the National Institutes of Health. Compared to infants born to mothers who had COVID-19 during pregnancy, infants born to vaccinated mothers were much more likely to have antibodies against the virus.

On average, scores on development tests were lower for infants born earlier in the range of a term pregnancy—from 37 to 41 weeks—than for those born later in the range, suggests a study by researchers at the National Institutes of Health. The slight difference in scores, first apparent at eight months, persisted through age seven. The findings may have implications for current practice guidelines recommending induction of labor for non-medical reasons at the 39th week of pregnancy.

An individual’s risk for death by suicide may begin before they are born, suggests a study by researchers at the National Institutes of Health. The authors compared pregnancy and birth records of nearly 50,000 individuals born between 1959 and 1966 to death records through 2016. They found that suicide rates were higher for males, white people, and for those who were among the younger siblings in a family. Other risk factors included having a parent with less than a high school education, having a parent who worked a manual labor job, and having a mother with a high rate of pregnancy complications or who smoked during pregnancy.

Read about NICHD’s research findings and activities from 2021.

It just got easier to participate in the PregSource®: Crowdsourcing to Understand Pregnancy research project. The free app allows participants to track their weight, sleep, mood, and other features of their pregnancy in just a few taps.

Dr. Grewal has been acting director of the division since February 2020.

NICHD Director Dr. Diana Bianchi is joined by NIH Office of Research on Women’s Health Director Dr. Janine Clayton in assessing the growing maternal health crisis in the United States and describing NIH’s efforts to address it.

Women facing eviction from their homes while they were pregnant are more likely to have poor birth outcomes, compared to women who faced eviction before or after they were pregnant, according to a study funded in part by NICHD.

A new study funded by the National Institutes of Health will evaluate the effects of remdesivir in pregnant women who have been prescribed the drug to treat COVID-19. The study, which will be conducted at 17 sites in the continental United States and Puerto Rico, aims to determine how pregnant women metabolize the drug and whether there are any potential side effects.

Pregnant people need to be protected through research rather than from research, the authors contend.

As the COVID-19 pandemic persists, SARS-CoV-2 vaccines offer the potential to halt the spread of the virus. Yet, we know very little about the effectiveness and safety of the vaccines during pregnancy.

NIH-funded study suggests mother-to-infant transmission appears to be rare